It's all about the timing.Novavax (NASDAQ: NVAX) is reportedly getting close to finalizing a major supply deal with the European Union. While that seems like very good news, some of the details emerging don't sound so great to some investors. In this Motley Fool Live video recorded on May 5, Motley ...

https://www.fool.com/investing/2021/05/15/why-novavaxs-pending-covid-vaccine-deal-with-the-e/?source=iedfolrf0000001

#fool